Author:
Lapkina E. Z.,Esimbekova A. R.,Beleniuk V. D.,Savchenko A. A.,Ruksha T. G.
Reference35 articles.
1. Al-Qatati, A. and Aliwaini, S., Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells, Oncol. Lett., 2017, vol. 14, p. 7993.
2. Avci, N.G., Ebrahimzadeh-Pustchi, S., Akay, Y.M., Esquenazi, Y., Tandon, N., Zhu, J.J., and Akay, M., NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways, Sci. Rep., 2020, vol. 10, p. 13352.
3. Beaumont, K.A., Hill, D.S., Daignault, S.M., Lui, G., Sharp, D.M., Gabrielli, B., Weninger, W., and Haass, N.K., Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells, J. Invest. Dermatol., 2016, vol. 136, p. 1479.
4. Bedikian, A.Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A.C., DeConti, R., Hersh, E.M., Hersey, P., Kirkwood, J.M., and Haluska, F.G., Oblimersen melanoma study group. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen melanoma study group, J. Clin. Oncol., 2006, vol. 29, p. 4738.
5. Cappel, S.D., Mark, K.G., Garbett, D., Pack, L.R., Rape, M., and Meyer, T., EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle, Nature, 2018, vol. 7709, p. 313.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献